Literature DB >> 3561042

Leiomyosarcomas and benign smooth muscle tumors of the stomach: nuclear DNA patterns studied by flow cytometry.

K Tsushima, L M Rainwater, J R Goellner, J A van Heerden, M M Lieber.   

Abstract

Paraffin-embedded archival tissue samples were used for determination of DNA ploidy by flow cytometry on 117 surgically resected gastric smooth muscle tumors (44 leiomyosarcomas, 53 leiomyomas, and 20 benign leiomyoblastomas). The technique of Hedley was used for preparation of paraffin-embedded tissue into single dissociated nuclei, and the method of Vindeløv was used for staining with propidium iodide. Among the 53 leiomyomas, the DNA ploidy pattern was diploid in most tumors (87%), except for 2 DNA tetraploid/polyploid and 5 DNA aneuploid samples. In comparison, the 20 benign leiomyoblastomas had more frequent abnormal DNA histograms: DNA tetraploidy/polyploidy in 5 (25%) and DNA aneuploidy in 2 (10%). The DNA histograms of the 44 leiomyosarcomas (including 4 epithelioid leiomyosarcomas) were classified as follows: 20 cases (45%) exhibited a DNA diploid pattern, 14 cases (32%) had a DNA tetraploid/polyploid pattern, and 10 cases (23%) had DNA aneuploid peaks. For the patients with leiomyosarcomas, the DNA ploidy pattern was significantly correlated with survival (P less than 0.001), as were tumor grade (P less than 0.001) and tumor size (P less than 0.05). Furthermore, both benign and malignant gastric smooth muscle tumors with DNA tetraploid/polyploid patterns were significantly larger than those with a DNA diploid histogram (P less than 0.05). DNA ploidy pattern cannot be used for diagnosis--that is, to distinguish malignant from benign gastric smooth muscle tumors. For gastric leiomyosarcomas, however, nuclear DNA ploidy pattern is an easily measured objective determination with important prognostic significance.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3561042     DOI: 10.1016/s0025-6196(12)61904-1

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  6 in total

1.  [Leiomyosarcoma of the esophagus. Clinical aspects, diagnosis and therapy based on an individual case].

Authors:  A C Pesarini; H Ernst; C Ell; C Wittekind; E G Hahn
Journal:  Med Klin (Munich)       Date:  1997-04-15

2.  Prognostic relevance of a novel proliferation marker, Ki-S11, for soft-tissue sarcoma. A multivariate study.

Authors:  P Rudolph; U Kellner; A Chassevent; F Collin; F Bonichon; R Parwaresch; J M Coindre
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

3.  Flow cytometric DNA measurements in benign and malignant Hürthle cell tumors of the thyroid.

Authors:  J J Ryan; I D Hay; C S Grant; L M Rainwater; G M Farrow; J R Goellner
Journal:  World J Surg       Date:  1988-08       Impact factor: 3.352

4.  DNA ploidy and c-Kit mutation in gastrointestinal stromal tumors.

Authors:  Ju Han Lee; Xianglan Zhang; Woon Yong Jung; Yang Seok Chae; Jong Jae Park; Insun Kim
Journal:  World J Gastroenterol       Date:  2004-12-01       Impact factor: 5.742

5.  Prognostic factors in primary gastrointestinal leiomyosarcoma: a retrospective study.

Authors:  H Kimura; Y Yonemura; N Kadoya; T Kosaka; K Miwa; I Miyazaki; T Sawa; S Yoshimitsu; Y Nishida; T Kamata
Journal:  World J Surg       Date:  1991 Nov-Dec       Impact factor: 3.352

6.  Stromal tumours of the gastrointestinal tract: a clinicopathological and ploidy analysis of 33 cases.

Authors:  E Lerma; E Oliva; D Tugués; J Prat
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.